Metformin vs Tolvaptan for Treatment of Autosomal Dominant Polycystic Kidney Disease

Condition:   ADPKD Interventions:   Drug: Metformin;   Drug: Tolvaptan Sponsor:   Azienda Ospedaliero-Universitaria Consorziale Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials